Text Size A A A

Sun Pharma In The News

Tell a Friend Print Home » Media » Sun Pharma In The News

EU backs Sun Pharma's generic drug

 

un Pharmaceutical Industries Ltd won the backing of European Union regulators to sell a generic version of Sanofi-Aventis SA's Taxotere cancer drug. The European Medicines Agency's Committee for Medicinal Products for Human Use recommended Docefrez, the regulator said today in a statement on its Web site. Sanofi sued Sun in August in the US, seeking to stop a generic copy there. The committee's decisions are usually adopted in a final  ruling by the European Commission. Taxotere is approved in the EU for breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck tumours, the agency said. ' Bloomberg